The meaning of "early" diagnosis in a new era of cystic fibrosis care

Pediatrics

Volumn 119, Issue 1, 2007, Pages 156-157

  Farrell, Philip M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUCLOXACILLIN;

CLINICAL FEATURE; CYSTIC FIBROSIS; EARLY DIAGNOSIS; HOSPITALIZATION; HUMAN; LUNG FUNCTION TEST; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; STAPHYLOCOCCUS INFECTION; SURVIVAL; NEWBORN; NEWBORN SCREENING;

CYSTIC FIBROSIS; EARLY DIAGNOSIS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 33846924392     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-3074     Document Type: Note

References (15)

1. Shwachman H, Redmond A, Khaw KT. Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period. Pediatrics. 1970;46:335-343
2. Report of the committee for a study for evaluation of testing for cystic fibrosis. J Pediatr. 1976;88(4 pt 2):711-750
3. Sims EJ, Clark A, McCormick J, et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics. 2007;119:19-28
4. Sokol RJ, Reardon MC, Accurso FJ, et al. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr. 1989;50:1064-1071
5. Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001;107:1-13
6. Waters DL, Wilcken B, Irwig L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed. 1999;80:F1-F7
7. Siret D, Bretaudeau G, Branger B, et al. Comparing the clinical evolution of cystic fibrosis (CF) screened neonatally to that of CF diagnosed from clinical symptoms: a 10-years retrospective study in a French region (Brittany). Pediatr Pulmonol. 2003;35:342-349
8. Littlewood JM, Bevan A, Connett G, et al. Antibiotic Treatment for Cystic Fibrosis: Report of the UK Cystic Fibrosis Trust Antibiotic Group. 2nd ed. Bromley, Kent, United Kingdom: Cystic Fibrosis Trust; 2002
9. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26:81-88
10. Stutman HR, Lieberman JM, Nussbaum E, Marks MI; Antibiotic Prophylaxis in Cystic Fibrosis Study Group. Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial. J Pediatr. 2002;140:299-305
11. Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004;53(RR-13):1-36
12. Farrell PM, Li Z, Kosorok MR, et al. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol. 2003;36:230-240
13. Farrell PM, Li Z, Kosorok MR, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med. 2003;168:1100-1108
14. US Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. Newborn Screening: Toward a uniform screening panel and system: report for public comment. Available at: www.mchb.hrsa.gov/screening. Accessed October 25, 2006
15. Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good than harm. J Pediatr. 2003;143:707-712